Publications by authors named "Corey Stone"

Claim this Profile
E
Establishing minimal clinically important differences for the Pemphigus Disease Area Index.
Henry Tseng, Corey Stone, Boaz Shulruf, Dédée F Murrell

Br J Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental triggers of pemphigus vulgaris and bullous pemphigoid: a case control study.
Corey Stone, Grace Bak, Daniel Oh, Cathy Zhao, Supriya Venugopal

Front Med (Lausanne)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions.
Ben Koszegi, Corey Stone, Norito Ishii, Takashi Hashimoto, Dédée F Murrell

J Eur Acad Dermatol Venereol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scoring Criteria for Autoimmune Bullous Diseases: Utility, Merits, and Demerits.
Henry Tseng, Corey Stone, Dédée F Murrell

Indian Dermatol Online J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Hidradenitis Suppurativa Responsive to Testosterone Replacement Therapy.
Corey Stone, Dedee F Murrell

Indian Dermatol Online J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare adverse event following laser hair reduction.
Corey Stone, Alexis Lara Rivero

Int J Womens Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases.
Henry Tseng, Corey Stone, Dédée F Murrell

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tildrakizumab for the treatment of hidradenitis suppurativa in patients previously treated with adalimumab: a 30-month experience.
Ben Koszegi, Anna Wilson, Corey Stone, Fanny Satgé, Timothy L Cowan

Clin Exp Dermatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia.
Ben Koszegi, Corey Stone, Dedee F Murrell

Front Med (Lausanne)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis